Vor Biopharma Inc.

VOR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$812,684-$1,573,669-$32,486-$30,712
Dep. & Amort.$2$2,100$825$865
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$1,933$1,709
Change in WC$5,057$4,629-$2,638$2,816
Other Non-Cash$753,963$1,531,756$1,300$1,259
Operating Cash Flow-$53,662-$35,184-$31,066-$24,063
Investing Activities
PP&E Inv.-$244-$152-$231-$72
Net Acquisitions$0$799$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0-$1$1$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$244$646-$230-$72
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$21,568$175,097-$551$55,528
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$19-$32-$55-$2,242
Financing Cash Flow$21,549$175,065-$606$53,286
Forex Effect-$168$2,413$0$0
Net Chg. in Cash-$32,525$142,940-$31,902$29,151
Supplemental Information
Beg. Cash$192,987$50,047$84,362$55,211
End Cash$160,462$192,987$52,460$84,362
Free Cash Flow-$53,906-$35,336-$31,297-$24,135
Vor Biopharma Inc. (VOR) Financial Statements & Key Stats | AlphaPilot